Top compounds associated with response to GYPC


Feature Type Standardized
Nominal ANOVA
mRNA AZD7762 GDSC1000 pan-cancer AAC 0.019 0.7
mRNA crizotinib:PLX-4032 (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.016 0.7
mRNA AT7867 CTRPv2 pan-cancer AAC -0.016 0.7
mRNA Gefitinib FIMM pan-cancer AAC -0.095 0.7
mRNA nelarabine CTRPv2 pan-cancer AAC 0.018 0.7
mRNA Gemcitabine gCSI pan-cancer AAC 0.031 0.7
mRNA Crizotinib gCSI pan-cancer AAC -0.032 0.7
mRNA SZ4TA2 CTRPv2 pan-cancer AAC 0.025 0.7
mRNA R428 CTRPv2 pan-cancer AAC -0.019 0.7
mRNA BRD-K96970199 CTRPv2 pan-cancer AAC 0.038 0.7
Download CSV